🇺🇸 FDA
Patent

US 10214732

Lysin agent and method of use for diagnostic testing

granted A61KA61K38/12A61K38/47

Quick answer

US patent 10214732 (Lysin agent and method of use for diagnostic testing) held by The United States of America, as represented by the Secretary of Homeland Security expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Homeland Security
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K38/12, A61K38/47